BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rijkers M, Schmidt D, Lu N, Kramer CSM, Heidt S, Mulder A, Porcelijn L, Claas FHJ, Leebeek FWG, Jansen AJG, Jongerius I, Zeerleder SS, Vidarsson G, Voorberg J, de Haas M. Anti-HLA antibodies with complementary and synergistic interaction geometries promote classical complement activation on platelets. Haematologica 2019;104:403-16. [PMID: 30262558 DOI: 10.3324/haematol.2018.201665] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Saris A, Pavenski K. Human Leukocyte Antigen Alloimmunization and Alloimmune Platelet Refractoriness. Transfus Med Rev 2020;34:250-7. [PMID: 33127210 DOI: 10.1016/j.tmrv.2020.09.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
2 Nagelkerke SQ, Porcelijn L, Geissler J, Tanck MWT, Huiskes E, van Bruggen R, van den Berg TK, de Haas M, Kuijpers TW. The association and functional relevance of genetic variation in low-to-medium-affinity Fc-gamma receptors with clinical platelet transfusion refractoriness. J Thromb Haemost 2020;18:2047-53. [PMID: 32588549 DOI: 10.1111/jth.14892] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Muller YD, Ferreira LMR, Ronin E, Ho P, Nguyen V, Faleo G, Zhou Y, Lee K, Leung KK, Skartsis N, Kaul AM, Mulder A, Claas FHJ, Wells JA, Bluestone JA, Tang Q. Precision Engineering of an Anti-HLA-A2 Chimeric Antigen Receptor in Regulatory T Cells for Transplant Immune Tolerance. Front Immunol 2021;12:686439. [PMID: 34616392 DOI: 10.3389/fimmu.2021.686439] [Reference Citation Analysis]
4 Meinke S, Karlström C, Höglund P. Complement as an Immune Barrier in Platelet Transfusion Refractoriness. Transfus Med Rev 2019;33:231-5. [PMID: 31679761 DOI: 10.1016/j.tmrv.2019.09.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
5 Enos AI, Hair PS, Krishna NK, Cunnion KM. A complement-mediated rat xenotransfusion model of platelet refractoriness. Mol Immunol 2020;124:9-17. [PMID: 32485436 DOI: 10.1016/j.molimm.2020.05.008] [Reference Citation Analysis]
6 Kapur R. Matching epitopes in platelet refractoriness. Blood 2021;137:283-4. [PMID: 33475748 DOI: 10.1182/blood.2020009283] [Reference Citation Analysis]
7 Zeeuw van der Laan EAN, van der Velden S, Bentlage AEH, Larsen MD, van Osch TLJ, Mok JY, Brasser G, Geerdes DM, Koeleman CAM, Nouta J, Semple JW, Porcelijn L, van Esch WJE, Wuhrer M, van der Schoot CE, Vidarsson G, Kapur R. Biological and structural characterization of murine TRALI antibody reveals increased Fc-mediated complement activation. Blood Adv 2020;4:3875-85. [PMID: 32810222 DOI: 10.1182/bloodadvances.2020002291] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Garraud O, Cognasse F, Moncharmont P. Immunological Features in the Process of Blood Platelet-Induced Alloimmunisation, with a Focus on Platelet Component Transfusion. Diseases 2019;7:E7. [PMID: 30646515 DOI: 10.3390/diseases7010007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
9 Åkesson A, Ljungkvist M, Martin M, Blom AM, Klintman J, Schött U, Zetterberg E, Kander T. Biomarkers of complement and platelet activation are not correlated with the one or twenty-four hours corrected count increments in prophylactically platelet transfused hematological patients: a prospective cohort study. Platelets 2021;:1-10. [PMID: 34210243 DOI: 10.1080/09537104.2021.1942817] [Reference Citation Analysis]